Trevena Reports Second Quarter 2019 Results

Trevena Reports Second Quarter 2019 Results

CHESTERBROOK, PA — Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System (CNS) conditions, reported its financial results for …

Read More